Taigen Biopharmaceuticals Holdings Ltd
TPEX:4157
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Taigen Biopharmaceuticals Holdings Ltd
TPEX:4157
|
TW |
|
G
|
Gold&S Co Ltd
KOSDAQ:035290
|
KR |
|
C
|
Cyfrowy Polsat SA
SWB:CP9
|
PL |
|
S
|
Stellar AfricaGold Inc
XMUN:6YP1
|
CA |
|
J
|
Japan Post Insurance Co Ltd
F:4JP
|
JP |
|
P
|
PCS Machine Group Holding PCL
SET:PCSGH
|
TH |
|
P
|
Panacos Pharmaceuticals Inc
OTC:PANC
|
US |
|
I
|
Intermonte Partners Sim SpA
F:78U
|
IT |
|
S
|
Steep Hill Inc
CNSX:STPH
|
CA |
|
B
|
Buligo Capital Ltd
TASE:BLGO
|
IL |
|
D
|
Direct Communication Solutions Inc
CNSX:DCSI
|
US |
|
R
|
ROY Asset Holding SE
SWB:RY8
|
DE |
|
Fleetpartners Group Ltd
ASX:FPR
|
AU |
Bankruptcy Probability
Taigen Biopharmaceuticals Holdings Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Taigen Biopharmaceuticals Holdings Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
T
|
Taigen Biopharmaceuticals Holdings Ltd
TPEX:4157
|
6.4B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
451.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
137.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Taigen Biopharmaceuticals Holdings Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Taigen Biopharmaceuticals Holdings Ltd has total debt of 7.2m TWD. This includes both short-term (0 TWD) and long-term (7.2m TWD) debt.
You can find a full breakdown on its Balance Sheet.
